Radiofrequency ablation in patients with hepatocellular carcinoma
β Scribed by Florence Aslinia; Ayse L. Mindikoglu
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 42 KB
- Volume
- 50
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
For the treatment of small hepatocellular carcinoma (HCC), radiofrequency ablation (RFA) is in some centers considered a first-line therapeutic option. However, such a strategy is still under debate with regard to tumor and patient characteristics. In this single-center study we assessed the 5-year
The high incidence of tumor seeding along the needle tract, reported by Llovet et al., 1 has not been reported as a complication of radiofrequency (RF) ablation of hepatocellular carcinoma (HCC) with the cooled needle in studies that date from 1996 and include several hundred patients. [2][3][4][5][
## Background: The therapeutic efficacy of radiofrequency ablation (rfa) for hepatocellular carcinoma (hcc) is limited by the small volume of coagulation necrosis obtained at each activation of the rf system and the sometimes irregular burn shape due to the proximity of large vessels that have a co